During the past decade, Biopharma Informatic, LLC conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 29 clinical trials were completed, i.e. on average, 42.6% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 28 clinical trials were completed. i.e. 65.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Biopharma Informatic, LLC" #1 sponsor was "Eli Lilly and Company" with 17 trials, followed by "Allergan" with 5 trials sponsored, "Shire" with 5 trials sponsored, "Pfizer" with 4 trials sponsored and "Phathom Pharmaceuticals, Inc." with 4 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Biopharma Informatic, LLC" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Dr. Falk Pharma GmbH" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Biopharma Informatic, LLC" are "Ulcerative Colitis" (10 trials), "Type 2 Diabetes" (8 trials), "Crohn's Disease" (5 trials), "Gastroparesis" (4 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Biopharma Informatic, LLC" in a lesser frequency.

Most popular intervention types in "Biopharma Informatic, LLC" are "Drug" (59 trials), "Other" (9 trials), "Biological" (5 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Tirzepatide" (5 trials), "Insulin Efsitora Alfa" (4 trials), "Ontamalimab" (4 trials) and "Vonoprazan" (4 trials). Other intervention names were less common.

The vast majority of trials in "Biopharma Informatic, LLC" are 64 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Biopharma Informatic, LLC". undefined are not yet recruiting, 17 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Biopharma Informatic, LLC, 1 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Biopharma Informatic, LLC, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".